We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, June 28th:
Atlas Air Worldwide Holdings, Inc. : This provider of aviation operating services has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 10.3% over the last 60 days.
Bunge Limited (BG - Free Report) : This owner and operator of agribusiness and food company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 25.6% over the last 60 days.
Automatic Data Processing, Inc. (ADP - Free Report) : This provider of business process outsourcing services has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 4.6% over the last 60 days.
Automatic Data Processing, Inc. Price and Consensus
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Top Ranked Momentum Stocks to Buy for June 28th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, June 28th:
Atlas Air Worldwide Holdings, Inc. : This provider of aviation operating services has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 10.3% over the last 60 days.
Atlas Air Worldwide Holdings Price and Consensus
Atlas Air Worldwide Holdings price-consensus-chart | Atlas Air Worldwide Holdings Quote
Atlas Air’s shares gained 0.8% over the last one month more than S&P 500’s gain of 0.4%. The company possesses a Momentum Score of A.
Atlas Air Worldwide Holdings Price
Atlas Air Worldwide Holdings price | Atlas Air Worldwide Holdings Quote
Bunge Limited (BG - Free Report) : This owner and operator of agribusiness and food company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 25.6% over the last 60 days.
Bunge Limited Price and Consensus
Bunge Limited price-consensus-chart | Bunge Limited Quote
Bunge’s shares gained 0.6% over the last one month. The company possesses a Momentum Score of B.
Bunge Limited Price
Bunge Limited price | Bunge Limited Quote
Automatic Data Processing, Inc. (ADP - Free Report) : This provider of business process outsourcing services has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 4.6% over the last 60 days.
Automatic Data Processing, Inc. Price and Consensus
Automatic Data Processing, Inc. price-consensus-chart | Automatic Data Processing, Inc. Quote
Align Technology’s shares gained 2.4% over the last one month. The company possesses a Momentum Score of B.
Automatic Data Processing, Inc. Price
Automatic Data Processing, Inc. price | Automatic Data Processing, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>